NICE publishes draft guidance on the use of a topical gel by patients with a rare cancer

NICE

5 August 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using chlormethine gel in the NHS in England.

Chlormethine gel is not recommended, within its marketing authorisation, for treating mycosis fungoides-type cutaneous T-cell lymphoma in adults.

Clinical evidence shows that chlormethine gel relieves skin symptoms. But there is no robust evidence showing its effectiveness compared with phototherapy.

Read NICE appraisal consultation document

Michael Wonder

Posted by:

Michael Wonder